Discussion The clinical management of patients with type 2 diabetes has to balance the potential benefits of controlling hyperglycemia on microvascular and macrovascular complications, [11] with possible side effects of treatment and possible harm from over intensive control of glycemia
The studies were conducted in a variety of countries (USA, Sweden, Germany, Denmark, and China), which increased the generalizability of the findings across populations
She described the return of intense cravings and a biological drive to overeat that no amount of willpower could suppress
"Medicare Coverage of GLP-1 Drugs." IF12758
Bartunek J, Croissant JD, Wijns W, Gofflot S, de Lavareille A, Vanderheyden M, Kaluzhny Y, Mazouz N, Willemsen P, Penicka M, et al